Addis Ababa, March 20, 2025 (ENA)—Members of the parliament (MPs) are directing questions to Prime Minister Abiy Ahmed today at the session of the House of People's Representatives. The MPs are ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

The ability to write parts of SQL queries in natural language will help developers speed up their work, analysts say. Google is previewing a new AI-driven feature in its BigQuery data warehouse that ...

In response to fan research that shows a clear desire to see the best golfers competing together more often – as well as timely inquiries from players not currently competing on the PGA TOUR and ...

Just about every stop on the second-home circuit has had its reality TV moment. The Hamptons is the backdrop for Bravo’s Summer House. VH1 aired Secrets of Aspen, set in that winter wonderland almost ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After winning the Eurovision Song Contest, Italian outfit Måneskin became the hottest rock band in the world. They sold out arenas and stadiums all over and nabbed a Best New Artist nomination at the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...